SCHEMBL4843117

SCHEMBL4843117

CC([O-])=S.[Cs+]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426159 0.89
SCHEMBL4947312 0.89
SCHEMBL7008604 0.89
Lithium Ion SCHEMBL3889583 0.89
SCHEMBL4948681 0.89
SCHEMBL48308 0.89
SCHEMBL9156588 0.89 CA1 (0.42)
Potassium Ion SCHEMBL9688 0.89
SCHEMBL22070012 0.89
SCHEMBL10366909 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117623998-A Application of perfluorocarbon sulfur-based silver reagent in synthesis of aryl perfluoroethyl sulfide 万博新材料科技(南通)有限公司 2024-03-01 CN claimed
US-20080268044-A1 Novel Process and Formulations GLAXO GROUP LIMITED 2008-10-30 US claimed
EP-1954282-A2 NOVEL PROCESS AND FORMULATIONS GLAXO GROUP LIMITED (GB) 2008-08-13 EP claimed
WO-2007059500-A2 NOVEL PROCESS AND FORMULATIONS GLAXO GROUP LIMITED (GB) 2007-05-24 WO claimed
US-20010014754-A1 Method for producing optically active phenylpropionic acid derivative AJINOMOTO CO., INC. (JP) 2001-08-16 US claimed
US-6031121-A Method for producing optically active phenylpropionic acid derivative AJINOMOTO CO., INC. (JP) 2000-02-29 US claimed
US-5627278-A MULTISTAGE REACTION FORMED BY AMIDATION, COUPLING AND REDUCTION BRISTOL-MYERS SQUIBB CO. (US) 1997-05-06 US claimed
US-10000512-B2 Compounds for the treatment of infectious diseases HOFFMANN-LA ROCHE INC. (US) 2018-06-19 US disclosed
EP-3204392-A1 COMPOUNDS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES F. Hoffmann-La Roche AG (CH) 2017-08-16 EP disclosed
US-20170217990-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES HOFFMANN-LA ROCHE INC. (US) 2017-08-03 US disclosed
WO-2016055553-A1 COMPOUNDS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2016-04-14 WO disclosed
US-20080268044-A1 Novel Process and Formulations GLAXO GROUP LIMITED 2008-10-30 US disclosed
US-7365091-B2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX ENOBIA PHARMA (CA) 2008-04-29 US disclosed
WO-1996014327-A1 ANTIFUNGAL SORDARIDIN DERIVATIVES GLAXO WELLCOME S.A. (ES) 1996-05-17 WO disclosed
US-5508272-A SELECTIVE ACE INHIBITORS, HYPOTENSIVE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1996-04-16 US disclosed
WO-1995029932-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-Δ4-3-KETOSTEROIDS VIA 4-NITRO-Δ4-3-KETOSTEROIDS MERRELL PHARMACEUTICALS INC. (US) 1995-11-09 WO disclosed
EP-0680962-A2 Heterocyclic compounds ZENECA LIMITED (GB) 1995-11-08 EP disclosed
WO-1995010516-A1 TRICYCLIC AMIDE AND UREA COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES SCHERING CORPORATION (US) 1995-04-20 WO disclosed
EP-0629627-A2 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1994-12-21 EP disclosed
EP-0599444-A1 Dual action inhibitors E.R. SQUIBB &amp; SONS, INC. (US) 1994-06-01 EP disclosed